Respiratory Therapy Zone’s Post

1) Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines. As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective and infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness, disability and death. 2)AMR is a natural process that happens over time through genetic changes in pathogens. Its emergence and spread is accelerated by human activity, mainly the misuse and overuse of antimicrobials to treat, prevent or control infections in humans, animals and plants.

New research identifies metabolic targets to combat antibiotic-resistant bacterial infections. Study reveals how targeting unique metabolic pathways in specific pathogens could lead to precision antibiotics, offering a solution to antimicrobial resistance. Read: https://lnkd.in/e4p2vBSG

New research identifies metabolic targets to combat antibiotic-resistant bacterial infections. Study reveals how targeting unique metabolic pathways in specific pathogens could lead to precision antibiotics, offering a solution to antimicrobial resistance. Read: https://lnkd.in/eDMndBEN

Sesame protein-derived peptides have demonstrated potential in combating E. coli and S. aureus infections 🌿💪 These findings hold promise for developing natural antimicrobial agents to combat antibiotic-resistant bacteria #SesameProtein #PeptideResearch #AntimicrobialPotential

🎥 Watch Our New Film on Bacteriophages — Nature’s Own Solution to bacterial infections and antibiotic resistance! 🎥 Have you ever wondered if viruses could be good for us? It turns out, they can. Bacteriophages — viruses that infect and kill bacteria — are one of nature’s most ingenious tools for controlling bacterial populations. As we face the growing threat of antimicrobial resistance (AMR), phages are emerging as a potential game-changer for global health. Our Microbial Genomics Group at Małopolska Centre of Biotechnology UJ has been exploring this exciting frontier. And now, we’re proud to share a short, engaging film that explains the science behind bacteriophages, why they matter, and how our research aims to harness their unique potential. This was possible thanks to the Strategic Programme Excellence Initiative at the Uniwersytet Jagielloński (Jagiellonian University). 📽️ Watch the film in 🇬🇧 here: https://lnkd.in/d4VpQ2Z4 📽️ Watch the film in 🇵🇱 here: https://lnkd.in/dtBZNh7w 🦠 What makes bacteriophages so special? • Highly Specific – Bacteriophages target only specific bacteria, leaving beneficial microbiota unharmed. • Adaptable – Bacteriophages evolve naturally alongside bacterial pathogens, and with the right tools, we can guide this process. • Evolutionary Powerhouses – Phages can exchange genes and evolve rapidly, allowing them to outpace bacterial resistance. 🔍 What’s our research focus? Our team investigates the mosaic-like structure of bacteriophage genomes and proteins. Bacteriophages are natural “genome shufflers,” recombining their genetic material to adapt to bacterial defences. By studying this process, we aim to create a roadmap for the design of bespoke phages to target drug-resistant bacteria, offering a precision tool for combating AMR. This could transform how we treat infections in hospitals, safeguard public health, and reduce the reliance on antibiotics. 📢 Why should you care? If left unchecked, antimicrobial resistance could kill 8 million people annually by 2050. Phage-based therapies offer a promising, natural solution. Our film illustrates how the science works and why phage research is critical for the future of healthcare. Whether you’re a researcher, healthcare professional, or just curious about nature’s hidden superpowers, this film will give you a new perspective on the “good viruses” that could one day save lives. 📢 Share your thoughts — I’d love to hear your reactions or questions about phages, phage therapy, and our ongoing research. #Bacteriophages #PhageTherapy #AntimicrobialResistance #AMR #Biotechnology #InfectiousDiseases #FutureOfHealthcare #PhageResearch #MosaicGenomes #ScienceCommunication

When you kill the fungus, the mycotoxins released from the dying fungal cells can trigger a secondary inflammatory response. This response is often referred to as a Jarisch-Herxheimer-like reaction, but specifically in the context of fungal infections, it's called a "fungal die-off reaction" or "fungal toxin release reaction". However, some sources also refer to this reaction as "Candida die-off" or "fungal cytokine storm".

➡️➡️A vulvar 🌸swab for the detection of mycoplasma is a test used to detect the presence of bacteria from the Mycoplasma genus, which can cause genital infections. This test is typically performed when symptoms like pelvic pain, abnormal discharge, or signs of urinary infection are present. The most commonly tested Mycoplasma species in this context are Mycoplasma genitalium and Mycoplasma hominis, which can be involved in infections of the genital and urinary tracts. The swab involves taking a sample of cells from the vulva or cervix using a sterile cotton swab. The sample is then sent to a laboratory for analysis, usually through PCR (Polymerase Chain Reaction) or bacterial culture, to detect the presence of these microorganisms. If the test is positive, antibiotic treatment may be prescribed based on the results and antibiogram.

this new strategy aims to catch the bacteria in an evolutionary dilemma — one in which they cannot evade phages and antibiotics simultaneously, causing a no-win situation for antibiotic resistance bacteria https://lnkd.in/g6RZqaTD